UbiQGel

UbiQGel is a biotechnology company focused on developing advanced hydrogel-based drug delivery systems and 3D cell culture models. The company's proprietary platform utilizes synthetic, biomimetic hydrogels that can be customized to mimic the extracellular matrix of various tissues, facilitating more accurate drug screening and regenerative medicine applications. By providing a highly controlled environment for cell growth and drug interaction, UbiQGel aims to improve the predictability of preclinical studies and enhance the efficacy of therapeutic delivery. Their technology is particularly applicable in oncology for modeling solid tumors and developing localized drug delivery solutions. The company operates at the intersection of materials science and biology to address critical gaps in drug development and patient care.